Neurodegenerative diseases, such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and amyotrophic lateral sclerosis (ALS), affect millions of people worldwide.
Neurodegenerative diseases occur when nerves in the central nervous system (CNS) lose function over time and die, resulting in a loss of specific brain functions, such as memory, movement, and cognition.
Neuregulin (NRG) Potential in Neurodegenerative Diseases
Diverse roles of NRG in the nervous system... treatment candidate in numerous neurodegenerative conditions
Neuregulins (NRGs) play a key role in developing, maintaining, and repairing the CNS. NRG-1 has shown early promise in treating neurodegenerative diseases and SalubrisBio is assessing JK07’s potential as a treatment for several neurodegenerative conditions. Our first neurology clinical trial is expected to begin in 2023.